We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
-7.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.86M
AUM Growth
-$188M
Cap. Flow
-$186M
Cap. Flow %
-1,882.29%
Top 10 Hldgs %
17.98%
Holding
708
New
41
Increased
5
Reduced
51
Closed
611

Top Buys

Rank Stock Value
1
ACVA icon
ACV Auctions
ACVA
+$194K
2
RPD icon
Rapid7
RPD
+$183K
3
EFC
Ellington Financial
EFC
+$181K
4
SAN icon
Banco Santander
SAN
+$159K
5
OSCR icon
Oscar Health
OSCR
+$155K

Top Sells

Rank Stock Value
1
EXLS icon
EXL Service
EXLS
+$830K
2
DK icon
Delek US
DK
+$724K
3
AVGO icon
Broadcom
AVGO
+$669K
4
ITRI icon
Itron
ITRI
+$666K
5
EAT icon
Brinker International
EAT
+$649K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.83%
2 Technology 15.87%
3 Healthcare 10.98%
4 Industrials 10.86%
5 Real Estate 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIK icon
126
Anika Therapeutics
ANIK
$202M
– –
-21,524
Closed -$207K
APH icon
127
Amphenol
APH
$194B
– –
-1,839
Closed -$249K
APOG icon
128
Apogee Enterprises
APOG
$816M
– –
-6,220
Closed -$226K
APPS icon
129
Digital Turbine
APPS
$1.11B
– –
-82,744
Closed -$414K
ARCC icon
130
Ares Capital
ARCC
$13.6B
– –
-11,400
Closed -$231K
ARES icon
131
Ares Management
ARES
$27.2B
– –
-1,325
Closed -$214K
ARI
132
Apollo Commercial Real Estate
ARI
$901M
– –
-22,350
Closed -$216K
ARLO icon
133
Arlo Technologies
ARLO
$1.44B
– –
-27,831
Closed -$389K
ARM icon
134
Arm
ARM
$309B
– –
-2,261
Closed -$247K
AROC icon
135
Archrock
AROC
$6.71B
– –
-8,614
Closed -$224K
AROW icon
136
Arrow Financial
AROW
$682M
– –
-9,559
Closed -$300K
EFOR
137
Everforth Inc
EFOR
$751M
– –
-7,411
Closed -$357K
ASND icon
138
Ascendis Pharma A/S
ASND
$16.7B
– –
-1,122
Closed -$239K
ASPN icon
139
Aspen Aerogels
ASPN
$450M
– –
-33,808
Closed -$95.7K
ASTL icon
140
Algoma Steel
ASTL
$406M
– –
-32,839
Closed -$135K
ATAT icon
141
Atour Lifestyle Holdings
ATAT
$4.25B
– –
-5,130
Closed -$202K
ATRO icon
142
Astronics
ATRO
$3.41B
– –
-10,091
Closed -$456K
AUR icon
143
Aurora
AUR
$12.4B
– –
-36,463
Closed -$140K
AVA icon
144
Avista
AVA
$3.43B
– –
-9,095
Closed -$351K
AVGO icon
145
Broadcom
AVGO
$1.84T
– –
-1,932
Closed -$669K
AVO icon
146
Mission Produce
AVO
$1.12B
– –
-35,560
Closed -$412K
AVT icon
147
Avnet
AVT
$7.37B
– –
-4,503
Closed -$217K
AWI icon
148
Armstrong World Industries
AWI
$6.46B
– –
-2,833
Closed -$541K
AWK icon
149
American Water Works
AWK
$25.7B
– –
-3,148
Closed -$411K
AWR icon
150
American States Water
AWR
$3.39B
– –
-3,300
Closed -$239K
4 5
6
7 8

Similar funds

WA
Wilshire Advisors Santa Monica, California $9.96M AUM 76.57% 1-Year Est. Return
BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
AIA
Acute Investment Advisory Mesa, Arizona $8.91M AUM 4.28% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
T
Transce3nd Kyle, Texas $11.3M AUM 11.23% 1-Year Est. Return

PharVision Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, PharVision Advisers held 708 positions worth $9.86M, down 95% from $198M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

PharVision Advisers withdrew a net $186M in Q1 2026, closing 611 positions and reducing 51 holdings. Its most notable exit was EXL Service, an estimated $830K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PharVision Advisers opened a new position in ACV Auctions worth $125K.

  • PharVision Advisers's largest Q1 2026 buy was ACV Auctions: 29,579 shares worth $125K.
  • PharVision Advisers added most to Embecta in Q1 2026, an estimated $48.4K increase.
  • PharVision Advisers's biggest Q1 2026 reduction was Herbalife, cutting an estimated $621K.
  • PharVision Advisers fully exited EXL Service in Q1 2026, selling an estimated $830K.
  • PharVision Advisers's ten largest holdings make up 18% of its $9.86M portfolio in Q1 2026.
  • PharVision Advisers opened 41 new positions and closed 611 in Q1 2026.
  • PharVision Advisers's portfolio value fell 95% quarter-over-quarter to $9.86M.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.